Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS)

Lignende værker

• Reply to MacLeod et al.: Multiple myeloma plasma cells have chameleon characteristics
  af: Breitkopf, Susanne B., et al.
  Udgivet: (2013)
• Bcr-Abl tyrosine kinase inhibitors- current status
  af: Mughal, Anum, et al.
  Udgivet: (2013)
• Bcr-Abl Tyrosine Kinase Inhibitors in the Treatment of Pediatric CML
  af: Carofiglio, Francesca, et al.
  Udgivet: (2020)
• Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
  af: Leoni, Veronica, et al.
  Udgivet: (2015)
• Renovascular hypertension from the BCR‐ABL tyrosine kinase inhibitor ponatinib
  af: Amin, Syed O., et al.
  Udgivet: (2020)